Clinical trial

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

NCT01070524

Study summary

ClinicalTrials.gov

Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention CHF 5188 pMDI Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Budesonide extrafine pMDI Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Seretide(r) Evohaler(r) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-01-01

PhasePHASE2

Conditions

Asthmaverified · MONDO: asthma

Interventions

CHF 5188 pMDIDRUG

Budesonide extrafine pMDIDRUG

Seretide(r) Evohaler(r)DRUG

Sponsors & collaborators

Chiesi Farmaceutici S.p.A.lead sponsor

Mapped research locations

ManchesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01070524 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.